Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

NCT04855136 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped Business objectives have changed

Conditions

Interventions

Sponsor

Celgene